journal article·2025-08-06Open access

Current Research Trends and Hotspots in Radiotherapy Combined with Nanomaterials for Cancer Treatment: A Bibliometric and Visualization Analysis

Muyasha Abulimiti, Shiqin Dai, Ebara Mitsuhiro, Yu Sugawara, Yinuo Li, Hideyuki Sakurai, Yoshitaka Matsumoto

Nanomaterials· Volume 15· Issue 15

Abstract

This study investigated the evolving trends, current research hotspots, and future directions of radiotherapy combined with nanobiomaterials through a bibliometric analysis. Publications related to nanobiomaterials used in radiotherapy between 2004 and 2024 were retrieved from the Web of Science Core Collection database and analyzed using VOSviewer, R, and CiteSpace. China emerged as the leading contributor, accounting for 1051 publications (50.41%), followed by the USA. Liu Zhuang is the most productive author in this field. American Chemical Society (ACS) Nano published the most influential articles and accumulated the highest number of citations. Advanced Targeted Therapies in Cancer: Drug Nanocarriers, the Future of Chemotherapy was the most cited, with 1255 citations. Citation bursts have revealed emerging research trends in targeted delivery, cellular studies, co-delivery strategies, immunogenic cell death, polymeric nanoparticles, tumor research, and drug delivery systems, indicating potential avenues for future research. Over the past two decades, nanomaterials for radiotherapy have gained substantial attention. Key areas of focus include enhancing the efficacy of radiotherapy, achieving targeted drug delivery, minimizing adverse effects, and integrating nanomaterials with other therapeutic modalities. Future investigations are expected to improve the precision of radiotherapy, augment radiation effects, and optimize the tumor microenvironment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Radiation Therapy and Dosimetry · Advanced Radiotherapy Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiation Oncology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba 305-8575, Japan

Research Center for Functional Materials, National Institute for Materials Science (NIMS), Tsukuba 305-0044, Japan

Graduate School of Pure and Applied Sciences, University of Tsukuba, Tsukuba 305-8575, Japan

Department of Materials Science and Technology, Tokyo University of Science, Tokyo 125-8585, Japan

Proton Medical Research Center, University of Tsukuba Hospital, Tsukuba 305-8576, Japan

Department of Radiation Oncology, Clinical Medicine, Institute of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan

Department of Radiobiology, Biomedical Science, Institute of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan

Funding

Japan–China Sasakawa Medical Fellowship and JST SPRING

References (57)

Show source-provided references
1. Pokropivny, V., Lohmus, R., Hussainova, I., Pokropivny, A., and Vlassov, S. (2007). Introduction to Nanomaterials and Nanotechnology, University of Tartu.
2. Aloss, K., and Hamar, P. (2023). Recent preclinical and clinical progress in liposomal doxorubicin. Pharmaceutics, 15.10.3390/pharmaceutics15030893 ↗
3. Doxil®—The first FDA-approved nano-drug: Lessons learned10.1016/j.jconrel.2012.03.020 ↗
4. Mirkin, C.A., Meade, T.J., Petrosko, S.H., and Stegh, A.H. (2015). Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer, Springer.10.1007/978-3-319-16555-4 ↗
5. 100 citation classics from the Journal of the American Medical Association10.1001/jama.1987.03390010056028 ↗
6. bibliometrix: An R-tool for comprehensive science mapping analysis10.1016/j.joi.2017.08.007 ↗
7. Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy10.1002/adma.201802228 ↗
8. Improving radiotherapy in cancer treatment: Promises and challenges10.18632/oncotarget.18409 ↗
9. Cancer radiosensitizers10.1016/j.tips.2017.11.003 ↗
10. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer10.1038/s41392-020-0150-x ↗
11. Wong, W.K., Guerra Liberal, F.D., and McMahon, S.J. (2022). DNA repair inhibitors potentiate fractionated radiotherapy more than single-dose radiotherapy in breast cancer cells. Cancers, 14.10.3390/cancers14153794 ↗
12. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma10.1186/s12943-023-01839-2 ↗
13. Quantitative single-cell comparison of sensitization to radiation and a radiomimetic drug for diverse gold nanoparticle coatings10.1002/smsc.202400053 ↗
14. Norquest, C.J., Rogic, A., Gimotty, P.A., Maitz, C.A., Rindt, H., Ashworth, H.L., Bryan, J.N., Donnelly, L.L., McCleary-Wheeler, A.L., and Flesner, B.K. (2024). Effects of neoadjuvant zoledronate and radiation therapy on cell survival, cell cycle distribution, and clinical status in canine osteosarcoma. Front. Vet. Sci., 11.10.3389/fvets.2024.1237084 ↗
15. Understanding radiation response and cell cycle variation in brain tumour cells using Raman spectroscopy10.1039/D3AN00121K ↗
16. An NIR Discrete Metallacycle constructed from Perylene Bisimide and Tetraphenylethylene Fluorophores for imaging-guided cancer Radio-chemotherapy10.1002/adma.202106388 ↗
17. The Schemes, Mechanisms and Molecular Pathway Changes of Tumor Treating Fields (TTFields) Alone or in Combination with Radiotherapy and Chemotherapy10.1038/s41420-022-01206-y ↗
18. Therapeutic Potentials of Resveratrol in Combination with Radiotherapy and Chemotherapy during Glioblastoma Treatment: A Mechanistic Review10.1186/s12935-021-02099-0 ↗
19. WEE1 Kinase Limits CDK Activities to Safeguard DNA Replication and Mitotic Entry
20. The Challenge of Combining Chemo- and Radiotherapy with Checkpoint Kinase Inhibitors10.1158/1078-0432.CCR-20-3358 ↗
21. Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions10.1053/j.semnuclmed.2020.05.003 ↗
22. Therapeutic modification of hypoxia10.1016/j.clon.2021.08.014 ↗
23. Overcoming radioresistance with the hypoxia-activated prodrug CP-506: A pre-clinical study of local tumour control probability10.1016/j.radonc.2023.109738 ↗
24. Combining radiotherapy with targeted therapies in non-small cell lung cancer: Focus on anti-EGFR, anti-ALK and anti-angiogenic agents10.21037/tlcr-20-552 ↗
25. Prospects of nanoparticle-based radioenhancement for radiotherapy10.1039/D3MH00265A ↗
26. Zheng, Y., and Sanche, L. (2023). Mechanisms of nanoscale radiation enhancement by metal nanoparticles: Role of low energy electrons. Int. J. Mol. Sci., 24.10.3390/ijms24054697 ↗
27. Villalobos Gutiérrez, P.T., Muñoz Carrillo, J.L., Sandoval Salazar, C., Viveros Paredes, J.M., and Gutiérrez Coronado, O. (2023). Functionalized metal nanoparticles in cancer therapy. Pharmaceutics, 15.10.20944/preprints202306.1125.v1 ↗
28. Advanced biomedical applications of carbon nanotube10.1016/j.msec.2019.03.043 ↗
29. Updates of nanotheranostics in cancer management10.52155/ijpsat.v46.2.6569 ↗
30. Carbon-based nanomaterials for cancer therapy via targeting tumor microenvironment10.1002/adhm.201800525 ↗
31. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS
32. Radioactive polymeric nanoparticles for biomedical application10.1080/10717544.2020.1837296 ↗
33. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine10.1016/j.addr.2019.05.012 ↗
34. Targeted delivery of nano-radiosensitizers for tumor radiotherapy10.1016/j.ccr.2024.216101 ↗
35. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability10.1016/j.ijpharm.2021.120586 ↗
36. Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking10.7150/thno.5366 ↗
37. Recent Advances in Silica-Based Nanomaterials for Enhanced Tumor Imaging and Therapy10.1021/acsabm.4c01318 ↗
38. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions10.1002/jbm.a.36550 ↗
39. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer10.1016/j.actbio.2019.02.031 ↗
40. Current trends in silica based drug delivery systems
41. The development of small-molecule inhibitors targeting CD4710.1016/j.drudis.2020.11.003 ↗
42. Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy (Adv. Healthcare Mater. 26/2023)10.1002/adhm.202370157 ↗
43. Chen, X., Xu, Z., Li, T., Thakur, A., Wen, Y., Zhang, K., Liu, Y., Liang, Q., Liu, W., and Qin, J.J. (2024). Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy. Biomark. Res., 12.10.1186/s40364-023-00551-z ↗
44. Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy10.1186/s40580-024-00466-x ↗
45. Aljabali, A.A., Obeid, M.A., Gammoh, O., El-Tanani, M., Mishra, V., Mishra, Y., Kapre, S., Srivatsa Palakurthi, S., Hassan, S.S., and Nawn, D. (2024). Nanomaterial-driven precision immunomodulation: A new paradigm in therapeutic interventions. Cancers, 16.10.3390/cancers16112030 ↗
46. Recent advances in ultrasound-triggered drug delivery through lipid-based nanomaterials10.1016/j.drudis.2020.09.026 ↗
47. Han, J., Zhao, D., Li, D., Wang, X., Jin, Z., and Zhao, K. (2018). Polymer-based nanomaterials and applications for vaccines and drugs. Polymers, 10.10.3390/polym10010031 ↗
48. Metal-based nanomaterials in biomedical applications: Antimicrobial activity and cytotoxicity aspects10.1002/adfm.201910021 ↗
49. Recent progress on asymmetric carbon-and silica-based nanomaterials: From synthetic strategies to their applications10.1007/s40820-021-00789-y ↗
50. Díez-Pascual, A.M. (2021). Carbon-based nanomaterials. Int. J. Mol. Sci., 22.10.3390/ijms22147726 ↗
51. Protein-based nanomaterials and nanosystems for biomedical applications: A review10.1016/j.mattod.2020.11.015 ↗
52. Recent strategies to develop polysaccharide-based nanomaterials for biomedical applications10.1002/marc.201400406 ↗
53. Recent advances in pH-responsive nanomaterials for anti-infective therapy10.1039/D0TB02177F ↗
54. Temperature-responsive smart nanocarriers for delivery of therapeutic agents: Applications and recent advances10.1021/acsami.6b00371 ↗
55. A review of multifunction smart nanoparticle based drug delivery systems10.2174/1381612828666220422085702 ↗
56. Theranostic nanoparticles10.2967/jnumed.114.146019 ↗
57. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy10.1016/j.jconrel.2014.12.008 ↗